The device is cleared to treat moderate to severe major depressive disorders in adults aged 18 and older, as a standalone treatment or alongside other treatments, who are not considered resistant to medication.
Analysis:SpaceX's Starship test strengthens IPO case, though hurdles remain Source: www.channelnewsasia.com
A 28-year-old woman from Uganda, who developed mild symptoms including body ache, was shifted from a hotel to the State-run...
Among the more recent reinterpretations is “Gregoria Lakambini: A Pinay Pop Musical” by Tanghalang Pilipino, which places Ka Oryang, played...
Canadian citizens, permanent residents and other foreign nationals who have been in affected areas in recent weeks and do not...
We often hear this advice given to spouses, "Huwag mong ibigay lahat!" It is framed as a survival tool or...
Originally developed for aggressive blood cancers, CAR-T cell therapy is now being explored as a possible breakthrough treatment for autoimmune...
